IndraLab

Statements


LY294002 inhibits JUN. 2 / 4
| 2

reach
"In parallel, Akt and MAPK signals were examined in cells treated as in Fig. 3 A; the results indicated that the combined treatment of fludarabine/LY294002 markedly attenuated Akt and Erk1/2 activation[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"Interestingly, the addition of LY294002, SP600125 and PD98059 prevented the fibroin stimulation of c-Jun (XREF_FIG)."